WELLS FARGO & COMPANY/MN - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 50 filers reported holding APREA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,7475,278
+3670.0%
0.00%
Q3 2022$0140
-76.9%
0.00%
Q2 2022$0607
+532.3%
0.00%
Q1 2022$096
+1.1%
0.00%
Q4 2021$0
-100.0%
95
-99.7%
0.00%
Q1 2021$155,000
+474.1%
30,301
+448.6%
0.00%
Q4 2020$27,000
-90.9%
5,523
-55.4%
0.00%
Q3 2020$298,000
-33.9%
12,370
+6.5%
0.00%
Q2 2020$451,000
+86.4%
11,619
+66.6%
0.00%
Q1 2020$242,000
+908.3%
6,973
+1225.7%
0.00%
Q4 2019$24,0005260.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,437,0002.66%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$214,0000.30%
Redmile Group, LLC 694,918$3,551,0000.06%
Quantamental Technologies LLC 13,752$70,0000.05%
KENNEDY CAPITAL MANAGEMENT LLC 342,486$1,750,0000.04%
PDT Partners, LLC 87,734$448,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$383,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,100$251,0000.01%
NEXT Financial Group, Inc 11,347$58,0000.01%
Sugarloaf Wealth Management, LLC 1,500$8,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders